Abstract. The inhibitor of differentiation 1 (Id1) protein is required for tubulogenesis, but the molecular signalling pathways remain unclear. Overexpression (Id1-t) or downregulation (si-Id1) of Id-1 in cell lines, were used to study the function of Id1. The expression of Id1 and β1-integrin was assessed by Western blotting. Up-regulation of Id1 in human umbilical vascular endothelial cells (HUVECs) activated the expression of β1-integrin and promoted cell adhesion and spreading. Conversely, down-regulation of Id1 suppressed β1-integrin expression and inhibited tubulogenesis. By using a β1-integrin antibody to inhibit β1-integrin function, we demonstrated that Id1-induced cell adhesion and tubulogenesis were mediated by β1-integrin. In addition, HUVECs overexpressing Id1 were able to promote capillary tube formation through cytoskeleton reorganization and cell contraction. Finally, the Rho-kinase inhibitor Y27632 inhibited tubulogenesis induced by Id1. Our findings provide evidence that Id1 regulates tubulogenesis in vitro through β1-integrin and Rho-kinase signalling.
Introduction
Controlled angiogenesis is vital for normal organ development and tissue repair, while angiogenesis can sustain tumorigenesis and age-related macular degeneration (1) . In addition, angiogenesis is a key event in the pathogenesis of some forms of cardiovascular disease (2) . Although angiogenesis has been identified as a key development in many progressive diseases, the specific molecular mechanisms of angiogenesis are not well understood.
The four Id (inhibitor of differentiation or DNA binding) proteins (Id1-4) all contain a helix-loop-helix motif that inhibits the activity of basic helix-loop-helix transcription factors by restraining DNA binding. The Id1 protein has been implicated in the regulation of the cell cycle and in differentiation (3) . Since the initial discovery that Id1 is required for angiogenesis (4), Id1 protein induced-angiogenesis has been studied in several experimental systems. Transplantation of mature endothelial cells overexpressing Id1 may serve as a novel and useful strategy for therapeutic angiogenesis (5) . Studies have also indicated that the overexpression of Id1 protein was correlated with angiogenesis in tumors (6) . Although the molecular mechanisms of Id1-mediated cell proliferation and apoptosis have been identified (7) , little is known about the mechanism of Id1-mediated angiogenesis.
Angiogenesis is a complex event and requires a wellorchestrated integration of migration, proliferation, extracellular matrix (ECM) degradation, cell contraction, and survival. Previous studies reported that Id1 can regulate cell migration (5), proliferation (5) and ECM degradation (8) . However, cellmatrix adhesion and F-actin cytoskeleton reorganization, which play crucial roles in endothelial cell adhesion during angiogenesis (9, 10) , were absent. Moreover, cytoskeletal regulatory molecules are probably involved in angiogenesis (11) . Furthermore, angiogenesis requires a polarized morphology with a single, broad lamellipod at the front that contains an actin cytoskeletal meshwork associated with many static cellmatrix adhesions (12) . Therefore, the mechanisms underlying endothelial cell (EC) morphogenesis are likely to be critical for angiogenesis. We propose that Id1 regulates angiogenesis by remodelling cell-matrix adhesion and through cytoskeleton reorganization.
In the present study, we investigated whether Id1 can regulate cell-matrix adhesion and the cell contractility of endothelial cells to control angiogenesis. We uncovered a novel signalling system whereby Id1 regulates angiogenesis through expression of β1-integrin and activation of the Rho-kinase Generation of Id1-t and si-Id1. The HUVECs-pIRES (con-t) and the HUVECs-Id1 transfectants (Id1-t) were established as previously described (13) . Stable transfectants were selected with by cultivation with 800 µg/ml geneticin (G418, SigmaAldrich) after transfection. The surviving colonies were collected after 3 weeks. A stable Id1 si-RNA vector was generated using a previously described method (14) . Briefly, the primers with short hairpin RNA sequences targeting the Id1 coding region were cloned into the pSuppressor-Retro vector to generate the siRNA expression vector. The sequences of the si-Id1 primers were: si-Id1-F, TCG AGG CTG TTA CTC ACG CCT CAA GGA AGC TTG CTT GAG GCG TGA GTA ACA GCC TTT TT; si-Id1-R, CTA GAA AAA GGC TGT TAC TCA CGC CTC AAG CAA GCT TCC TTG AGG CGT GAG TAA CAG CC. The control vector was generated using the same procedures as the siRNA vector, and the short hairpin RNA sequence was replaced with nonsense sequences that are not homologous to the human genome. The sequences of the control primers (14) were: si-con-F, TCG AGC GTA TTG CCT AGC ATT ACG TGA TGC TTG ACG TAA TGC TAG GCA ATA CGC TTT TT; si-con-R, CTA GAA AAA GCG TAT TGC CTA GCA TTS CGT CAA GCT TCA CGT AAT GCT AGG CAA TAC GC. The resulting vectors were then transfected into HUVECs using Lipofectin (Life Technologies) in accordance with the manufacturer's instructions. Positive si-Id1 and si-con clones were then selected in neomycin (200 µg/ml) and stable transfectants were isolated after 3 weeks of drug selection.
Cell attachment and spreading assays. For cell attachment assays, cells were gently trypsinized and suspended in serumfree medium at 1.5x10 5 cells/ml and 300 µl of cell suspension was added to each well in 24-well plates. After 30 min, unattached cells were removed by washing with PBS, and attached cells were treated with trypsin and counted with a haemocytometer.
To assess cell spread on collagen I gels, diluted collagen I (500 µg/ml) in serum-free medium was added to 12-well plates (500 µl/well). After the diluted collagen had polymerized at 37˚C, 1.2x10 5 cells were added to each well. Photographs were taken after 24 h and cell areas (spread) were quantified using the ImageTool software.
For antibody blocking analysis, the cells were mixed with β1-integrin antibody (10 µg/ml) for 15 min and then plated at 1.2x10 5 cells/well.
Collagen gel contraction. For collagen gel contraction assays (11), 600 µl cushions of 2 mg/ml collagen I were prepared in 24-well plates. Next, HUVECs (5x10 5 /well) were seeded in serum-free medium. After all cells had attached, the medium was removed and cells were overlaid with fresh medium containing 600 µl of 2 mg/ml collagen I, which subsequently polymerized. Gel diameters were monitored with a dissecting microscope two days later.
Western immunoblotting. Cells were washed three times with ice-cold PBS, and lysates were prepared in buffer containing 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 10 mM Tris-HCl, 0.2 mM PMSF and protease inhibitors. Protein concentration was determined by the BCA method. Equal amounts of protein were loaded onto each lane of a 12% SDS-PAGE gel. After blotting, polyvinylidene difluoride membranes were blocked for 2 h in 5% milk powder in TBS-Tween at room temperature. Membranes were then incubated with primary antibodies overnight at 4˚C. The binding of secondary HRP antibodies was visualized by ECL or ECL Plus. The band of the Western blot analyses was quantified with Quantity One software. Normalizing for total cell protein was performed using β-actin.
Flow cytometry. The cell suspension was centrifuged at 1000 rpm for 5 min, and the cells resuspended in blocking buffer (49 ml RIPA-1640, 1 g BSA, 1 ml fetal calf serum) on ice for 15 min. Some cell pellets were treated with β1-integrin-FITC antibody (2 µg/tube) except the control. The pellets were dispersed, mixed well, and incubated on ice for 1 h with agitation every 20 min to prevent cell sedimentation and clumping. The cells were washed by adding 3 ml of wash buffer (100 ml RIPA-1640, 1 g BSA) to the tubes, and centrifuged at 1000 rpm for 5 min at 4˚C. The supernatant was aspirated, and the cell pellet dispersed by flicking the tube. These steps were repeated. After a final wash, the cells were resuspended in the sample tube to a final concentration of 3x10 6 cells/ml in wash buffer.
F-actin staining. Human umbilical vascular endothelial cells were washed three times with PBS, plated on glass coverslips, and fixed for 30 min in PBS with 3.7% formaldehyde. Fixed cells were then treated with 0.1% Triton X-100 for 10 min. The F-actin was directly stained with rhodamine-phalloidin (1:100) for 30 min after blocking in 1% BSA for 30 min at room temperature. Cell nuclei were counterstained with 4', 6-diamidino-2-phenylindole (DAPI) in the mounting medium. Cells were washed three times with PBS and photographed using a confocal microscope.
In vitro tube formation. The in vitro tube formation (15) assay was performed using a matrigel basement membrane matrix (BD Biosciences). Matrigel, kept on ice, was placed in 24-well culture plates at 200 µl/well. The plates were then incubated at 37˚C for 30 min to allow the matrigel to solidify. HUVECs were seeded at 10 4 cells/well on the top of the solidified matrigel, and the plate was incubated at 37˚C for 24 h. Tube formation on matrigel was observed and analyzed under the microscope. The degree of angiogenesis was measured by multiplying the number of branch points by the total number of branches.
Statistical analysis. Data are given either as mean ± SD or as proportions. In cases of significant differences between the groups, multiple comparisons between groups were made by a modified Student's t-test with the Bonferroni correction. Comparisons between 2 groups were made by independent t-test.
Results

Id1 is required for endothelial cell tubulogenesis.
To investigate the mechanisms of Id-mediated tubulogenesis, we established two transfectant clones, Id1 overexpression (Id1-t) and knockdown (si-Id1), and then investigated whether ectopic Id1 expression in HUVECs could lead to tubulogenesis. Results showed that Id1 expression in Id1-t clones was ~180% higher than that in control transfectant clones (con-t), while si-Id1 clones has just 30% Id1 expression compared to con-t clones (Fig. 1A) . We then studied the tube forming ability of endothelial cells with higher or lower Id1 expression. The formation of capillary-like structures on matrigel by HUVECs was low in si-Id1 clones (Fig. 1B) . Compared with control cells, there was a 30% increase in the length of tubulogenesis in Id1-t clones, while there was an ~3-fold decrease in si-Id1 clones compared to control siRNA clones (Fig. 1C) .
Id1 is critical for cell adhesion and spreading. Cell adhesion and spread play critical roles in the angiogenic process. To determine whether Id1 protein was required for HUVECs adhesion, we cultured Id1-t, si-Id1, con-t and si-con clones on collagen-coated plates in serum-free medium. We found that Id1-t HUVECs adhered to the matrix more efficiently than control HUVECs, while the number of si-Id1 HUVECs adhering to collagen I was significantly decreased in the same time ( Fig. 2A) . Quantitative analysis of the number of adherent cells showed that Id1-t cells had a 2-fold higher number of adherent cells than the control group, while si-Id1 HUVECs had a 2-fold reduction in adherent cells (Fig. 2B) . Cell area is critical for cell survival and cell function, so we examined the different cell spreading areas induced by Id1. Results showed that Id1-t HUVECs had a larger spreading area than control HUVECs, while si-Id1 HUVECs had a smaller spreading area on collagen I (Fig. 2C ). Quantitative analysis of the cell area by ImageTool demonstrated that Id1-t HUVECs had a much larger spreading area than con-t clones, while si-Id1 HUVECs had a much smaller cell spreading area than either Id1-t or control clones (Fig. 2D) .
Id1-induced cell adhesion and spreading is β1-integrin dependent.
In order to determine whether Id1 could induce endothelial cell adhesion by integrin-dependent ECM interactions, we examined the effect of Id1 on the expression of β1-integrin in HUVECs. The Id1 overexpression led to the increased expression of β1-integrin, while Id1 knockdown nearly abolished β1-integrin expression (Fig. 3A) . In addition, flow cytometry analysis indicated that Id1-t cells exhibited a 1.5-fold induction of β1-integrin protein compared with control ECs; however, si-Id1 cells showed a 60% reduction in β1-integrin relative to control ECs (Fig. 3B) .
To determine whether Id1-induced cell adhesion was dependent on the function of β1-integrin, we treated cells with β1-integrin antibody. This treatment resulted in a 75% inhibition of cell attachment. Although Id1 overexpression increased the EC attachment, the β1-integrin antibody inhibited attachment of Id1-t cells to collagen I (Fig. 3C) . These experiments indicate that the expression of β1-integrin can be mediated by Id1 and that Id1 also controlled cell adhesion to collagen I through the cell surface protein β1-integrin.
In additional experiments, we used a β1-integrin inhibitory antibody to examine the Id1-induced tubulogenesis in vitro. The results showed that capillary like-structures were abrogated by β1-integrin antibody even in Id1-t cells (Fig. 3D) , suggesting that Id1-induced cell adhesion, spread and tubulogenesis are β1-integrin-dependent.
Id1 regulates EC actin stress fibre formation and contraction of collagen I gels.
Previous reports have shown that β1-integrin is vital for the disassembly of the actin cytoskeleton (16) and cytoskeleton is critical for cell contraction (17) . Therefore, the next series of experiments were aimed at gaining further information about the role of Id1 in endothelial cell actin cytoskeleton organization and cell contraction. Cells overexpressing Id1 had more cytoplasmic F-actin and actin stress fibres than control cells, while si-Id1 cells had attenuated actin stress fibres and appeared tightly connected with a characteristic peripheral rim of F-actin (Fig. 4A) . Actin stress fibres are critical for cell contraction; therefore, cell contractility induced by Id1 was assessed. Results showed that Id1 overexpression significantly increased the contraction of collagen I gels (Fig. 4B) .
Id1-induced EC cytoskeleton and contraction depend on
Rho-kinase. Rho GTPases are critical for regulating cytoskeleton organization, and have a prominent role in the control of cell migration and contraction (18) . To investigate whether Rho-kinase is involved in Id1-enhanced endothelial contraction and tubulogenesis, we treated cells with 10 µM of the highly specific Rho-kinase inhibitor, Y27632. This antagonist abolished the Id1-enhanced cytoskeleton formation completely and F-actin was strictly localized to the peripheral rim. The cytoskeleton in control cells was also significantly altered (Fig. 5A) . Results showed that Y27632 also prevented Id1-induced contraction of collagen I gels (Fig. 5B) . These data indicate that inhibition of Rho-kinase not only prevented the formation of Id1-induced actin stress fibres but also reduced HUVECs contraction. We next used Y27632 to examine whether Id1-induced tubulogenesis was mediated through Rho-kinase activity. Indeed, the same dose of Y27632 also destroyed capillary network formation (Fig. 6 ). These data suggest that Id1-induced actin stress fibres and contractility were mediated by Rho-kinase signalling and by the tension generation by the cytoskeleton.
Discussion
The aim of this study was to investigate the molecular mechanisms of tubulogenesis mediated by Id1 protein. We characterized the mechanisms by which Id1 regulates tubulogenesis through the cell-matrix adhesion protein β1-integrin and by cytoskeletal reorganization, leading to enhanced cell contractility. Both up-regulation of β1-integrin and the cytoskeletal rearrangements/cell contractility associated with tubulogenesis were dependent on the Rho-kinase signalling cascade. This work demonstrates that Id1-induced tubulogenesis is associated with changes in cell adhesion and spreading, possibly mediated by β1-integrin, and that Id1 regulated the expression of β1-integrin. The F-actin cytoskeleton and the Rho family kinases were involved in tubulogenesis induced by Id1 overexpression, and Id1 controlled cell contraction. Thus, our findings provide insight into the molecular mechanisms of Id1-regulated tubulogenesis. Cell adhesion to ECM is a dynamic process involving attachment, spread, and formation of focal adhesions and stress fibres that generate a strong adhesive state (19) . The strong adhesive state is characteristic of a differentiated, quiescent cell, whereas cells in the intermediate adhesive state include those involved in responding to injury during wound healing or tissue remodelling (20) . Cell shape can regulate cell fate and function (21) and actin cytoskeleton is critical for cell volume (22) . In the present study, we found that Id1 protein could induce cell adhesion and spreading. Therefore, Id1-induced cell adhesion and spreading could contribute to the Id1 related tubulogenesis.
Integrins, cytoskeletal proteins, and focal adhesion kinase (FAK) are critical for cell adhesion in three-dimensional (3D) matrices derived from tissues or in 2D cell culture. β1-integrin is essential for EC adhesion, migration, and survival during tubulogenesis (23) . Animal models have demonstrated that β1-integrin is a critical adhesion molecule to induce therapeutic tubulogenesis in cell-based therapy (24) . The Id1 and β1-integrin proteins are well known for their role in regulating tubulogenesis, but up to now no research has shown that Id1 induces the expression of β1-integrin and that Id1-induced tubulogenesis is dependent on β1-integrin. The mechanism by which Id1 regulates the expression of β1-integrin is still not clear. Recently, it was reported that p53 expression may regulate the recycling of β1-integrin (25) , and Id1 can regulate the expression of p53 (26) . We propose that the interaction of Id1 and p53 is essential for Id1-mediated expression of β1-integrin, a possibility that will be addressed in future study.
The Rho family of small GTPases is involved in a series of complex biochemical networks that regulate cytoskeletal dynamics, morphogenesis, polarity, movement and cell division (27) . Reorganization of the F-actin cytoskeleton is critical for endothelial cell migration and tubulogenesis (9). Limiting the formation of actin stress fibres and focal contacts in the adhering endothelial cells, and inhibition of adhesion, suppresses their angiogenic properties (16, 19) . The organization of the F-actin (as well as the microtubule) network and formation of cell-matrix adhesions in response to extracellular cues are controlled by small GTPases of the Rho family (18) . Signalling by Rho/ROCK was shown to be an important mediator of a number of angiogenic processes induced by VEGF (11) . This is consistent with our in vitro results that Id1 expression influenced the F-actin cytoskeleton during tubulogenesis and that Y27632 efficiently abolishes adhesion and migration of endothelial cells and capillary tube formation induced by Id1. The functional significance of F-actin cytoskeletal rearrangement and Rho family proteins in modulating Id1-mediated tubulogenesis has not been previously reported. Modulation of tubulogenesis by Id1 appears to depend on reorganization of the F-actin cytoskeleton mediated by Rho family signalling.
Our results have several important implications. The mechanisms through which Id1 regulates the expression of β1-integrin are currently unknown. We showed that Id1-induced tubulogenesis by cell adhesion and cytoskeletal reorganization. This finding may prove critical for studies on how mechanical stimuli regulate cytoskeletal organization. Indeed, the expression of Id1 can be regulated by mechanical stimuli (28) .
In conclusion, our current investigation identifies a novel mechanism for Id1-induced tubulogenesis: Id1 induces tubulogenesis by regulating endothelial cell adhesion and cytoskeletal organization through β1-integrin and Rho-kinase signaling. Id1-induced tubulogenesis was dependent on β1-integrin and corresponding changes in cell adhesion and spreading. This link should be further explored and may provide clues for the management of tubulogenesis related disease. In particular, Id1-induced tubulogenesis by cell adhesion and cytoskeletal reorganization demonstrated that Id1 can be used either to suppress or enhance cell adhesion by β1-integrin and cell cytoskeletal reorganization by Rho-kinase. This study may lay a foundation for new rational therapeutic strategies to control new blood vessel formation.
